These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1007 related items for PubMed ID: 19580892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J.
    Vaccine; 2006 Jan 16; 24(3):335-44. PubMed ID: 16125280
    [Abstract] [Full Text] [Related]

  • 5. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein.
    Mota J, Acosta M, Argotte R, Figueroa R, Méndez A, Ramos C.
    Vaccine; 2005 May 16; 23(26):3469-76. PubMed ID: 15837370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice.
    Konishi E, Kosugi S, Imoto J.
    Vaccine; 2006 Mar 15; 24(12):2200-7. PubMed ID: 16316713
    [Abstract] [Full Text] [Related]

  • 9. Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes.
    Khanam S, Etemad B, Khanna N, Swaminathan S.
    Am J Trop Med Hyg; 2006 Feb 15; 74(2):266-77. PubMed ID: 16474083
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, Bawa A, Selling B, Sardesai NY, Kim JJ, Weiner DB.
    Vaccine; 2009 Jul 09; 27(32):4370-80. PubMed ID: 19497647
    [Abstract] [Full Text] [Related]

  • 14. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
    Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K.
    Virology; 2006 Sep 15; 353(1):166-73. PubMed ID: 16814355
    [Abstract] [Full Text] [Related]

  • 15. Recent progress in dengue vaccine research and development.
    Miller N.
    Curr Opin Mol Ther; 2010 Feb 15; 12(1):31-8. PubMed ID: 20140814
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K, Perng GC.
    Exp Biol Med (Maywood); 2013 May 15; 238(5):566-78. PubMed ID: 23856907
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.